Bluewave Healthcare v. United States

853 F.3d 131
CourtCourt of Appeals for the Fourth Circuit
DecidedMarch 23, 2017
Docket16-1597; 16-1600; 16-1601
StatusPublished
Cited by39 cases

This text of 853 F.3d 131 (Bluewave Healthcare v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Fourth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Bluewave Healthcare v. United States, 853 F.3d 131 (4th Cir. 2017).

Opinion

Dismissed by published opinion. Judge Duncan wrote the opinion, in which Chief Judge Gregory and Judge Floyd joined

DUNCAN, Circuit Judge:

Appellants challenge the district court’s denial of their motions to quash writs of *135 attachment against real and personal property and writs of garnishment against two bank accounts. Because we conclude that the denial is an unreviewable interlocutory order, we dismiss for lack of jurisdiction.

I.

A.

In 2010, Floyd Calhoun Dent III (“Dent”) and Robert Bradford Johnson (“Johnson”) founded BlueWave Healthcare Consultants, Inc. (“BlueWave”), which served as the exclusive marketing agent for two blood test laboratories, Health Diagnostic Laboratories, Inc. (“HDL”) and Singulex. BlueWave operated pursuant to substantially similar sales agreements with both labs. Under the sales agreements, HDL and Singulex agreed to pay Blue-Wave a monthly base fee as well as commissions ranging between 13.8% and 24% of all lab revenue generated in BlueWave’s sales territory. 1 The labs would also pay a physician a “processing and handling fee” between $10 and $20 if the physician chose HDL or Singulex to process blood work. After performing the blood tests, the labs billed insurance companies — including federally funded insurance programs Medicare and TRICARE — for reimbursement. 2

B.

In 2014, two relators filed a qui tam action against Johnson, Dent, and Blue-Wave (collectively, “BlueWave Defendants”), and the United States intervened in April 2015. 3 The government alleged that BlueWave Defendants violated the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b (“AKS”), and False Claims Act, 31 U.S.C. § 3729 et seq. (“FCA”)'. An AKS violation that results in a federal health care payment is a per se false claim under the FCA. 42 U.S.C. § 1320a-7b(g). According to the government’s complaint, Blue-Wave Defendants, acting as sales agents on behalf of HDL and Singulex, arranged for illegal kickbacks to physicians under the guise of the processing and handling fees.

On February 5, 2016, the United States filed an application for prejudgment remedies under the Federal Debt Collection Procedures Act (“FDCPA”), 28 U.S.C. § 3001 et seq. Specifically, the government sought writs of attachment against personal and real property and writs of garnishment against bank accounts totaling approximately $16.7 million. 4 BlueWave Defendants as well as related nonparties, the Johnson and Dent entities, own the property. 5

*136 The government’s application recounted its evidence that BlueWave Defendants violated the AKS and FCA through the sales agreements and alleged that, as a result of this conduct, BlueWave Defendants owe the United States at least $298 million. The government also alleged prejudgment seizure was necessary because BlueWave Defendants were actively concealing and disposing of assets. On February 10, 2016, the district court held a hearing on the FDCPA application pursuant to 28 U.S.C. § 3101(a)(3)(A) and granted all of the writs except one. 6

The district court found that the government sufficiently alleged that BlueWave Defendants were debtors under the FDCPA because a person automatically incurs a debt once the government pays a fraudulent claim. The district court also concluded that, although the Johnson and Dent entities “are not parties to the underlying litigation” or “debtors within the meaning of the FDCPA,” their property was subject to attachment. J.A. 1507, 1510. With regard to the Johnson entities, the district court determined that their properties were subject to attachment pursuant to 28 § U.S.C. 3102(b) because the government had produced sufficient evidence to support a finding that Johnson has a “substantial nonexempt interest” in them. As to the Dent entities, the government argued it was entitled to prejudgment attachment under Subchapter D of the FDCPA, which governs fraudulent transfers. Id. § 3304(b)(1). If the government can establish that a debtor has made fraudulent transfers, the court can order “any other relief the circumstances may require.” Id. § 3306(a)(3). Finding that Dent had fraudulently transferred property to the Dent entities, the district court also granted writs of attachment as to them.

BlueWave Defendants, the Johnson entities, and the Dent entities (collectively, “Appellants”) each filed a motion to quash the writs. Following argument on May 5, 2016, the district court found that the government had satisfied the FDCPA’s statutory requirements and denied the motion. Appellants noticed this appeal, asserting that the denial of the motion to quash is immediately appealable under the collateral order doctrine and 28 U.S.C. § 1292(a)(1). In response, the government filed a motion to dismiss the appeal for lack of jurisdiction. We deferred ruling on that motion pending a review of the merits. Because we hold today that a party can only appeal an order denying a motion to quash writs of attachment or garnishment after final judgment, we grant the government’s motion to dismiss.

II.

Appellants assert various reasons why the government was not entitled to prejudgment writs of attachment and garnishment. We must first, however, consider the threshold issue of jurisdiction. United States v. Jefferson, 546 F.3d 300, 308 (4th Cir. 2008).

Article III courts are courts of limited jurisdiction, possessing only the authority granted by Congress and the Constitution. Kokkonen v. Guardian Life Ins. Co. of Am., 511 U.S. 375, 377, 114 S.Ct. 1673, 128 L.Ed.2d 391 (1994). Generally, a party may only appeal an order that is final, that is, nothing remains for the district court to do except execute the judgment. See 28 U.S.C. § 1291; Mohawk In *137 dus., Inc. v. Carpenter, 558 U.S. 100, 103, 130 S.Ct. 599, 175 L.Ed.2d 458 (2009). As relevant here, however, a party may appeal an interlocutory order in two narrowly defined circumstances.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
853 F.3d 131, Counsel Stack Legal Research, https://law.counselstack.com/opinion/bluewave-healthcare-v-united-states-ca4-2017.